CiteAb 2018 Antibody Awards

We are thrilled to announce our recent win at the CiteAb awards 2018

One of Abcam’s core goals is to make sure that life scientists have access to the best reagents for their research. We offer a global service to our customers and deliver to over 130 countries and provide multi-lingual support. This award is testament to our commitment to help scientists advance their research globally.

Antibody company with sustained success in China: Abcam

This award recognizes the antibody company which has seen sustained success in the Chinese market over the past five years.

Dr Andrew Chalmers, Founder of CiteAb, said: “The winner for this award, Abcam, was determined based on CiteAb citation data over a five-year period from 2013–2017.

"The company has done extremely well over the past year in multiple markets, and has clearly seen a great deal of success. With China being such an essential region to crack, it's great to see that Abcam has managed to do so!”

Learn more about our offices in China. 

We are also pleased to announce the other categories for which we were highly commended: 

  • Antibody company of the year
  • Researchers' choice
  • Antibody company succeeding in cancer biology

Sign up